ABSTRACT In this study we reevaluated whether the sole cause of mitral valve prolapse (MVP) and aortic valve prolapse (AVP) is myxomatous degeneration. Forty-two surgical cases of prolapsed valves with mitral and/or aortic regurgitation were reviewed (AVP in nine, MVP in 27, and combined AVP and MVP [CVP] 
MITRAL VALVE PROPLAPSE (MVP) is a clinical
syndrome that is usually diagnosed by echocardiography,'-7 angiocardiography,j12 and phonocardiography. '3' 14 It has also been known as redundant cusp syndrome,'5 floppy valve syndrome,'6 or ballooning deformity. 17 Recently, aortic valve prolapse (AVP) has also been diagnosed by echocardiography or by direct observation during surgery. 22 Mitral or aortic regurgitation and congestive heart failure are the late sequelae of this syndrome.
Surgeons performing valve replacement for the regurgitant prolapsed valve have been impressed with the characteristic gross appearance of the floppy valve. 15 16 Since the major histologic finding of the floppy valve is myxomatous degeneration, the etiology of the syndrome has been mostly related to the degenerative process and this entity has been recognized as a nonrheumatic change.'6' 17. [23] [24] [25] [26] [27] [28] [29] Recently, however, we noted histologic changes characteristic of chronic inflammation in several ex-cised prolapsed valves. To confirm this impression, we examined the excised specimens of the regurgitant prolapsed valves along with relevant clinical variables.
Methods
Forty-two consecutive surgical cases of regurgitant prolapsed valves and congestive heart failure at the University of Tokyo between 1978 and 1983 were reviewed. Twenty-five patients were men and 17 were women. Their ages ranged from 20 to 67 years (mean 43). Seven patients had a history suggestive of rheumatic fever. All patients had severe mitral (n = 27), aortic (n = 9), or combined mitral and aortic regurgitation (n = 6), and none had clinical valvular stenosis. The duration of symptoms ranged from 1 to 44 years (mean 12.8). The NYHA functional capacity was more than grade II in all patients. Atrial fibrillation was seen in 17 patients (63%) with mitral regurgitation, six (56%) with aortic regurgitation, and four (66%) with combined mitral and aortic regurgitation. This study did not include patients with atrial septal defect, ventricular septal defect, Marfan's syndrome, or other disease that may accompany mitral or aortic valve prolapse. The diagnosis of valve prolapse was made by two-dimensional echocardiographic and surgical findings.
On two-dimensional echocardiography, mitral valve prolapse (MVP) was diagnosed when the mitral cusps protruded into the left atrium crossing the plane of the mitral anulus. During surgery, MVP was diagnosed by one surgeon when the intact valves protruded beyond the optimal position into the left atrium. Morphologic diagnosis of MVP included doming or intrachordal hooding of the mitral cusp into the left atrium. Aortic valve prolapse (AVP) was also diagnosed by the surgeon when the aortic cusps protruded downward beyond the optimal position for closure of the valve. Two-dimensional echocardiography revealed various degrees of prolapse in all patients with MVP and in most with AVP. However, in three patients AVP diagnosed at surgery was not observed on echocardiography.
Based on the surgeon's description, MVP was graded as follows: grade I, prolapse of a small part of one cusp; grade II, prolapse of at least one-third of the posterior cusp or one-half of the anterior cusp; grade III, prolapse associated with major chordal rupture. AVP was graded as follows: grade I, prolapse of one cusp; grade II, prolapse of two cusps; grade III, prolapse of all three cusps. The mitral and/or aortic annular size and left ventricular size were evaluated by inspection. Gross abnormalities of the valve apparatus were also assessed.
A majority of the valves were removed in a uniform fashion. However, most of them were separated immediately into anterior and posterior cusps. The annular dimensions were measured in the resected aortic and mitral valves, the anulus of which was assessed by one pathologist. After Table 2 shows the sites of the prolapsing cusps of the aortic valves. Histologic classification of valve prolapse and relevant gross morphologic features. Twenty patients showed various degrees of myxomatous degeneration in the mitral valve (n = 13), aortic valve (n = 6), or both (n = 1). In the pars fibrosa of these specimens, collagen bundles were fragmented and disruption of the fibrosa was observed (figure 1). The majority of these valves had a widened pars spongiosa with moderate-to-marked acid mucopolysaccharide infiltration as demonstrated by alcian blue stain (figure 2). However, three patients with isolated MVP had degeneration of the pars fibrosa with minimal mucopolysaccharide infiltration. Three patients had minimal myxomatous degeneration in the chordae, which had been elongated or ruptured. Vascularization by thick-walled vessels with or without inflammatory round cell infiltration, which is the characteristic change of chronic inflammation or of a postinflammatory state, was not observed in these myxomatous valves. Therefore valves of this type were considered to show myxomatous valve prolapse (figure 3). The majority of the mitral cusps with myxomatous prolapse were large and were considered so-called floppy valves. 16 The aortic cusps of these valves showed a similar appearance. Thinning and enlargement of the cusps were seen in three mitral and four aortic valves.
In the other 22 patients, the mitral valve (n = 14), aortic valve (n = 3), or both (n = 5) were diffusely vascularized with scarring, suggesting postinflammatory and/or chronic inflammatory changes. Destruction of valve architecture was prominent, and the pars spongiosa was decreased or absent because of scarring in a majority of these valves (figure 4). In six patients, infiltration of chronic inflammatory round cells, including lymphocytes and plasma cells, was also observed. We will refer to this condition as "postinflammatory valve prolapse" (PIVP).
In both groups, patients with CVP had concordant histologic changes in aortic and mitral valves. PIVP in a mitral valve and the prolapse of the anterior cusp of the same valve at surgery. The cusps of the mitral valve with PIVP were relatively hard and thick, with minimal or moderate chordal fusion and thickening (figure 7). Seven cases of PIVP also showed chordal elongation. A soft mitral valve associated with myxomatous degeneration was seen in seven patients with PIVP. Both postinflammatory and myxomatous changes were observed in these valves (figure 8). The aortic cusps of PIVP were relatively hard (figure 9) and all cusps showed conspicuous prolapse toward the left ventricle at surgery.
Mitral Grade ofprolapsed portion. Table 4 shows the grades of MVP. Four cases of grade III MVP showed not only ruptured chordae tendeneae but also prominent doming of one or both cusps toward the left atrium. The incidence of more than grade II prolapse was higher in valves with myxomatous prolapse than in those with PIVP (p < .05). In grade I prolapse, chordal elongation and valvular deformities, including slight commissural fusion, were observed in three and marked annular dilatation in two. Table 5 shows the grades of AVP. All four prolapsed aortic valves of grade III were soft and large and belonged to the myxomatous prolapse group. The incidence of grade III AVP was higher in valves with myxomatous prolapse than in those with PIVP (p < .05). All three cases of grade I AVP had minimal cusp fusion with impairment of cusp coaptation.
Clinical and pathologicfeatures of va lve prolcapse in relati7on to histologic classification. 11 However, in the majority of patients with MVP or AVP the etiology in unknown, in which case the condition is considered as primary or idiopathic. The pathogenesis is tentatively attributed to the weakening of the pars fibrosa as in the types of secondary valve prolapse mentioned above. Almost all studies dealing with valve prolapse or floppy valve have emphasized the presence of myxomatous degeneration resulting from the degeneration of collagen in the pars fibrosa, which occurs by an unknown mechanism.' 17 23 26. 28 37 38 Several authors also described acid mucopolysaccharide infiltration or collagen degeneration shown by haphazard arrangement of fibrils with disruption or fragmentation. 23 Little attention has been paid to the relation of valve prolapse to postinflammatory changes or chronic valvulitis. Kern et al.37 demonstrated the presence of myxoid changes in valves showing the characteristic features of rheumatic valvulitis. Barlow38 also described the association of mitral valve prolapse with rheumatic fever. There was also one report on MVP associated with mitral stenosis.39 However, these studies gave no important clues to the etiology or pathogenesis of valve prolapse because of their vague definition of valve prolapse or the absence of clinical diagnosis by echocardiography. Echocardiographic diagnosis of MVP is generally made when the mitral leaflet protrudes into the left atrium crossing the valve ring; AVP is diagnosed when the aortic valve prolapses Although the absence of inflammatory changes has been considered as a hallmark of valve prolapse for clear-cut distinction from rheumatic valvulitis, we should not neglect the existence of PIVP with characteristic features of chronic valvulitis or postinflammatory changes. In PIVP, it seems unlikely that valve prolapse is caused simply by the weakening of the pars fibrosa of the aortic or mitral valve. Many other factors such as valvular deformity, annular dilatation, and elongated and/or ruptured chordae may contribute to valve prolapse. These other abnormalities of the valve apparatus were considered to be the cause of severe valvular regurgitation in the group with lower-grade PIVP. However, in the myxomatous valves with PIVP, weakening of the pars fibrosa could be a significant cause of valve prolapse.
The echocardiographic or angiocardiographic differentiation of PIVP from myxomatous prolapse may be difficult without pathologic examination. However, the age distribution in the two groups of patients may be a useful clue to the differential diagnosis of prolapse. The average age of patients with myxomatous prolapse was higher than that of patients with PIVP, and the onset of symptoms was at a younger age in patients with PIVP than in those with myxomatous prolapse. This is probably because myxomatous degeneration showed an increased incidence with increasing age'5 17 and because rheumatic fever and in-CIRCULATION fections are common in children. Our cases of regurgitant AVP and/or MVP associated with congestive heart failure represented late and severe stages of valve prolapse. Therefore our study may have included more cases of valve prolapse caused by postinflammatory changes than the actual incidence of PIVP. There may also be some patients with PIVP and mild clinical manifestations, and these cannot be differentiated easily from patients with "valve prolapse due to myxomatous degeneration or other etiologies." We conclude that (1) valve prolapse was attributable not only to myxomatous degeneration but also to postinflammatory changes, (2) valvular deformities, chordal elongation, and/or rupture were regarded as the initiating factors of PIVP, and (3) the patients with PIVP were younger than those with myxomatous prolapse, probably because rheumatic fever and infections commonly occur in children and adolescents.
